IDO1 and glioblastoma: Considering the work by our group and others in repeatedly demonstrating the remarkable pathogenic influence of IDO in subjects with GBM, the elucidation of its role and multi-variate functions may provide a path for enhancing the effectiveness of cancer immunotherapy against malignant glioma in the future.